Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations

Giulia Escobar, Marcela V Maus · 2026

Read Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations by Giulia Escobar, Marcela V Maus (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241626.txt.

Description

Giulia Escobar and Marcela V Maus present a 2026 review of combination strategies to make engineered T cell therapy work in pancreatic cancer. This cancer resists immunotherapy through dense scar-like tissue and a suppressive local environment. Engineered cells must enter the tumor and stay active once inside.

The authors discuss their recent preclinical work with cells aimed at mesothelin, a protein found on these tumors. One drug raised target levels on tumor cells by blocking its shedding. Another drug steered T cells toward a more helpful state. Blocking the PD-1 brake restored cell function in tumors carrying its partner protein. Combining such approaches, they argue, beats seeking a single fix.

Catalog record

CREATORGiulia Escobar, Marcela V Maus
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13241626

Browse the full library · About the Tower of Babel